These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3196365)

  • 1. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis.
    Bjorkman DJ; Hammond EH; Lee RG; Clegg DO; Tolman KG
    Arthritis Rheum; 1988 Dec; 31(12):1465-72. PubMed ID: 3196365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
    Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
    Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Ros S; Juanola X; Condom E; Cañas C; Riera J; Guardiola J; Del Blanco J; Rebasa P; Valverde J; Roig-Escofet O
    Scand J Rheumatol; 2002; 31(6):330-6. PubMed ID: 12492247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findings.
    Kremer JM; Kaye GI
    Arthritis Rheum; 1989 Oct; 32(10):1202-13. PubMed ID: 2803323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
    Kremer JM; Kaye GI; Kaye NW; Ishak KG; Axiotis CA
    Arthritis Rheum; 1995 Sep; 38(9):1194-203. PubMed ID: 7575712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
    Kremer JM; Lee RG; Tolman KG
    Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
    Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
    Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
    Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
    Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
    Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
    Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver ultrastructure in psoriatics related to methotrexate therapy. 1. A prospective study of findings in hepatocytes from 24 patients before and after methotrexate treatment.
    Nyfors A; Hopwood D
    Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):787-800. PubMed ID: 602766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR; Reddy V; Vogelgesang SA; West SG
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H; Arnson Y; Chodick G; Shalev V
    Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of methotrexate exposure and host factors on transcriptional variance in human liver.
    Belinsky GS; Parke AL; Huang Q; Blanchard K; Jayadev S; Stoll R; Rothe M; Achenie LE; Gupta RR; Wu GY; Rosenberg DW
    Toxicol Sci; 2007 Jun; 97(2):582-94. PubMed ID: 17400583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.